See more : Healthcare Capital Corp. (HCCCU) Income Statement Analysis – Financial Results
Complete financial analysis of CapStar Financial Holdings, Inc. (CSTR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CapStar Financial Holdings, Inc., a leading company in the Banks – Regional industry within the Financial Services sector.
- Hylink Digital Solution Co., Ltd. (603825.SS) Income Statement Analysis – Financial Results
- CNT Group Limited (0701.HK) Income Statement Analysis – Financial Results
- British Automotive Holding S.A. (BAH.WA) Income Statement Analysis – Financial Results
- American International Group, Inc. (AIG.SW) Income Statement Analysis – Financial Results
- Advanced Process Systems Corporation (265520.KQ) Income Statement Analysis – Financial Results
CapStar Financial Holdings, Inc. (CSTR)
About CapStar Financial Holdings, Inc.
CapStar Financial Holdings, Inc. operates as the bank holding company for CapStar Bank that provides banking services to consumer and corporate customers located primarily in Tennessee, the United States. Its deposit products and services include demand deposits, interest-bearing transaction accounts, money market accounts, time and savings deposits, certificates of deposit, and CDARS reciprocal products. The company also provides commercial and consumer real estate, construction and land development, commercial and industrial, consumer, PPP, and other loans. In addition, it offers mortgage banking products and services; private banking and wealth management services for the owners and operators of business clients and other high net worth individuals; and correspondent banking services to community banks. Further, the company provides telephone and online banking, direct deposit, mobile banking, safe deposit box, remote deposit, and cash management services for individuals, and small and medium sized businesses. CapStar Financial Holdings, Inc. was founded in 2007 and is headquartered in Nashville, Tennessee.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 181.16M | 120.61M | 133.85M | 119.57M | 92.02M | 67.15M | 52.77M | 49.55M | 43.66M | 39.84M | 36.53M |
Cost of Revenue | 22.97M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 158.19M | 120.61M | 133.85M | 119.57M | 92.02M | 67.15M | 52.77M | 49.55M | 43.66M | 39.84M | 36.53M |
Gross Profit Ratio | 87.32% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 40.31M | 38.07M | 41.76M | 45.25M | 35.54M | 28.59M | 20.40M | 20.46M | 19.28M | 17.47M | 16.02M |
Selling & Marketing | 0.00 | 900.00K | 800.00K | 400.00K | 370.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 40.31M | 38.07M | 41.76M | 45.25M | 35.54M | 28.59M | 20.40M | 20.46M | 19.28M | 17.47M | 16.02M |
Other Expenses | -25.88M | -90.98M | -114.23M | -134.09M | -98.30M | -73.69M | 0.00 | 0.00 | -46.18M | -44.03M | -35.81M |
Operating Expenses | 25.88M | -52.92M | -72.48M | -88.84M | -62.76M | -40.24M | 1.52M | 1.55B | -26.90M | -26.56M | -19.79M |
Cost & Expenses | 146.35M | -52.92M | -72.48M | -88.84M | -62.76M | -40.24M | 1.52M | 1.55B | -26.90M | -26.56M | -19.79M |
Interest Income | 158.19M | 113.53M | 98.46M | 91.85M | 91.55M | 67.78M | 51.52M | 45.39M | 40.50M | 38.29M | 41.16M |
Interest Expense | 4.52M | 17.44M | 7.29M | 15.53M | 23.80M | 16.09M | 9.65M | 6.93M | 5.73M | 5.87M | 6.58M |
Depreciation & Amortization | 2.82M | 1.69M | 1.94M | 1.82M | 1.66M | 1.03M | 450.00K | 422.48K | 506.00K | 625.04K | 656.00K |
EBITDA | 36.20M | 69.39M | 63.32M | 32.56M | 30.92M | 27.94M | 16.24M | 20.94M | 17.27M | 13.90M | 17.39M |
EBITDA Ratio | 19.98% | 57.53% | 47.30% | 27.23% | 33.60% | 41.61% | 30.77% | 42.27% | 39.55% | 34.89% | 47.61% |
Operating Income | 36.20M | 67.70M | 61.38M | 30.73M | 29.27M | 26.91M | 15.79M | 20.52M | 16.76M | 13.28M | 16.73M |
Operating Income Ratio | 19.98% | 56.13% | 45.85% | 25.70% | 31.80% | 40.08% | 29.92% | 41.42% | 38.39% | 33.32% | 45.81% |
Total Other Income/Expenses | -49.95M | -33.78M | -30.72M | -43.59M | -27.21M | -27.74M | -45.11M | 1.52B | 0.00 | 0.00 | -259.00K |
Income Before Tax | 36.20M | 48.77M | 61.38M | 30.73M | 29.27M | 10.82M | 6.14M | 13.59M | 11.03M | 7.40M | 10.16M |
Income Before Tax Ratio | 19.98% | 40.43% | 45.85% | 25.70% | 31.80% | 16.12% | 11.63% | 27.43% | 25.26% | 18.59% | 27.81% |
Income Tax Expense | 6.40M | 9.75M | 12.70M | 6.04M | 6.84M | 1.17M | 4.64M | 4.49M | 3.47M | 2.41M | 3.75M |
Net Income | 29.80M | 39.02M | 48.68M | 24.70M | 22.42M | 9.66M | 1.50M | 9.10M | 7.56M | 4.99M | 6.41M |
Net Income Ratio | 16.45% | 32.35% | 36.37% | 20.65% | 24.37% | 14.38% | 2.84% | 18.36% | 17.31% | 12.53% | 17.54% |
EPS | 1.41 | 1.77 | 2.20 | 1.22 | 1.25 | 0.67 | 0.13 | 0.98 | 0.70 | 0.46 | 0.59 |
EPS Diluted | 1.41 | 1.77 | 2.19 | 1.22 | 1.20 | 0.67 | 0.12 | 0.81 | 0.70 | 0.46 | 0.59 |
Weighted Avg Shares Out | 21.14M | 22.01M | 22.13M | 20.16M | 17.89M | 14.41M | 11.28M | 9.33M | 10.35M | 10.80M | 10.34M |
Weighted Avg Shares Out (Dil) | 21.17M | 22.06M | 22.18M | 20.19M | 18.61M | 14.48M | 12.80M | 11.21M | 10.80M | 10.80M | 10.80M |
CapStar Bank launches The Southeastern School of Banking Diversity Scholarship for Tennessee Students
Veteran Nashville Banker Joins CapStar as Commercial Relationship Manager
CapStar Financial Holdings, Inc. to Participate in the Piper Sandler East Coast Financial Services Conference
Capstar Financial Holdings Inc (NASDAQ:CSTR) Shares Bought by Nuveen Asset Management LLC
Capstar Financial Holdings Inc (NASDAQ:CSTR) Expected to Announce Quarterly Sales of $31.49 Million
Continuous Manufacturing Market for Biologics and Small Molecules 2020-2030 - ResearchAndMarkets.com
PetIQ, Inc. (PETQ) Q2 2020 Earnings Call Transcript | AlphaStreet
PetIQ, Inc. (PETQ) Q2 2020 Earnings Call Transcript | The Motley Fool
MyoKardia Heart Trial, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:MYOK)
Source: https://incomestatements.info
Category: Stock Reports